In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241
·
clinicaltrials.gov ↗
COMPLETED
Status
86
Enrollment
OTHER
Sponsor class
Conditions
In Utero SARS-CoV-2 Exposure
Interventions
OTHER:
In Utero Exposure to SARS-CoV-2
Sponsor
Massachusetts General Hospital